Vericel Corporation (NASDAQ: VCEL)
Vericel is a leading producer of autologous cell therapies with two unique FDA-approved products: MACI for cartilage defects in the knee and Epicel for severe body burns. The company has also signed an exclusive license and supply agreement for NexoBrid, a registration-stage product for the debridement of severe burns with an expected commercial launch in early 2021. Background:
Aastrom...